Cordyceps sinensis enhances the efficacy of anti-PD-1 immunotherapy in Lewis lung adenocarcinoma

Key Points

• The combination of cordyceps sinensis and anti-PD-1 immunotherapy significantly improves treatment response in Lewis lung adenocarcinoma.
• In preclinical models, the efficacy of anti-PD-1 was increased when paired with cordyceps sinensis treatment.
• Assessment of tumor progression rates in the presence of cordyceps sinensis indicates promising therapeutic potential for enhancing immunotherapy.
• The study highlights the need for further investigation into complementary therapies targeting lung cancer.